Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 6

MedCity News

A Biogen drug designed for a genetically defined form of amyotrophic lateral sclerosis led to patient improvement at a 12- month analysis, according to

  • 1573226121033924609 Profile photo of Madelyn

    So... does this additional info automatically give the FDA another 90 days to consider the application??? Biogen bolsters case for ALS drug under FDA review with new published data https://t.co/28zvoU4h7w - view on twitter